Dr Edwin Wagena
Chief Executive Officer
Ed is an experienced hands-on senior executive, trained as epidemiologist with a PhD in Medicine, with more than 20 years of experience in drug development.
Board
Steve Docksey
Executive Chairman
Steve has more than 30 years of successful business leadership experience in pharmaceuticals, biotechnology and life sciences with global giants including Millipore, Sartorius Stedim and GE Healthcare.
Professor Che Connon
Co-founder
Che is the scientific founder at Atelerix, and is passionate about cell biology and regenerative medicine.
Clive Stanway
Clive trained as a scientist in cell and molecular biology at Imperial College and Oxford University, rising to junior faculty status.
Andrew Muir
Andrew is a Director at the venture capital firm, Midven. As Fund Principal of the UK Innovation & Science Seed Fund and the Early Advantage Fund, Andrew led two rounds of investment into Atelerix
Dr Mick McLean
Director and Co-Founder
Mick is a chemist by training, a biologist by inclination and a business leader by experience.
Management Team
Dr Edwin Wagena
Chief Executive Officer
Ed is an experienced hands-on senior executive, trained as epidemiologist with a PhD in Medicine, with more than 20 years of experience in drug development.
Dr Steve Swioklo
Chief Scientific Officer
Steve is a co-founder of Atelerix and Chief Scientific Officer for the company, with a deep interest in the development of new technologies for biomedical applications.
Sanj Kumar
Chief Business Officer
Sanj is a highly accomplished life science executive and renowned sales and marketing leader, with extensive international experience.